AstraZeneca PLC Vice President Bahija Jallal, the head of its MedImmune LLC subsidiary, is leaving her corporate home of more than 12 years to take on the role of CEO at Immunocore Ltd., a clinical-stage firm focused on bispecific antibody candidates for cancer and other diseases – which has been partnered with AstraZeneca since 2014.
The Jan. 4 announcement came the same day as another AstraZeneca exec, Executive VP Mark Mallon, departed to take the...
Welcome to Scrip
Create an account to read this article
Already a subscriber?